NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities during the period of August 8, 2024 through August 14, 2025, inclusive (“the Class Period”). If you suffered a loss on your Nutex investments, you have until October 21, 2025 to request lead plaintiff appointment. Follow the link below for more information: [CONTACT THE F ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased iRobot Corporation securities between January 29, 2024, and March 11, 2025, of the September 5, 2025, deadline to serve as lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought iRobot securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by September 5, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that iRobot made false and misleading statements regarding its Restructuring Plan and its ability to operate profitably as a standalone company after the termination of the Amazon Acquisition [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3].

Core Viewpoint - A class action lawsuit has been filed against KinderCare Learning Companies, Inc. regarding its October 2024 initial public offering, alleging that the registration statement was misleading and failed to disclose significant issues related to child care quality and safety [1][5]. Group 1: Lawsuit Details - The lawsuit claims that KinderCare facilities experienced numerous incidents of child abuse, neglect, and harm, contradicting the company's assertion of providing "the highest quality care possible" [5]. - It is alleged that KinderCare did not meet basic care standards or comply with relevant laws and regulations governing child care, exposing the company to undisclosed risks of lawsuits and reputational damage [5]. - Investors are reportedly suffering damages as a result of the misleading information that was not disclosed prior to the IPO [5]. Group 2: Legal Process and Participation - Investors who purchased KinderCare common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before October 14, 2025, to serve as lead plaintiff, which involves directing the litigation on behalf of other class members [3][5]. - The Rosen Law Firm encourages investors to select qualified legal counsel with a successful track record in securities class actions [4].

Core Viewpoint - A class action lawsuit has been filed against Snap Inc. for misleading investors regarding its advertising revenue and growth potential during the specified Class Period from April 29, 2025, to August 5, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Snap's management created a false impression of reliable advertising revenue information while downplaying macroeconomic instability [5]. - It is alleged that Snap's optimistic reports on advertising growth did not reflect the reality of its operational challenges, leading to investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased Snap securities during the Class Period may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions for investors over the years [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased iRobot Corporation securities between January 29, 2024, and March 11, 2025, of the September 5, 2025, deadline to serve as lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - A class action lawsuit has been filed against iRobot, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2]. - Investors wishing to serve as lead plaintiff must file with the Court by September 5, 2025, and a lead plaintiff acts on behalf of other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that iRobot made false and misleading statements regarding its Restructuring Plan and its ability to operate profitably as a standalone company after the termination of the Amazon Acquisition [4]. - It is claimed that there was substantial doubt about iRobot's ability to continue as a going concern, and the public statements made by defendants were materially false and misleading [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Sable Offshore Corp. securities during the specified Class Period and secondary public offering about the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Sable securities between May 19, 2025, and June 3, 2025, or through the May 21, 2025, secondary public offering may be eligible for compensation without upfront costs [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 26, 2025 [3][5]. - The lawsuit alleges that Sable made materially false statements regarding its oil production activities, which misled investors about its business operations and prospects [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Centene Corporation securities between December 12, 2024, and June 30, 2025, of the September 8, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Centene securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5] - The deadline to move the Court to serve as lead plaintiff is September 8, 2025, with the lead plaintiff acting on behalf of other class members [2] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [3] Group 3: Case Allegations - The lawsuit alleges that Centene's defendants provided misleading information regarding the company's expected revenue guidance and adjusted diluted earnings per share for the 2025 fiscal year [4] - Defendants reportedly made positive statements about Centene's enrollment and morbidity rates while concealing adverse facts, leading to investor damages when the truth was revealed [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lockheed Martin securities between January 23, 2024, and July 21, 2025, about the upcoming lead plaintiff deadline on September 26, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Lockheed Martin securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is September 26, 2025, with the lead plaintiff acting on behalf of other class members [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Lockheed Martin made false and misleading statements regarding its internal controls and ability to meet contract commitments, which led to significant investor losses when the truth was revealed [5]. - Specific claims include the lack of effective internal controls, inaccurate program reviews, and overstated delivery capabilities, all of which contributed to misleading positive statements about the company's business prospects [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of RxSight, Inc. about a class action lawsuit due to alleged misleading statements and failure to disclose critical issues affecting the company's performance [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from November 7, 2024, to July 8, 2025 [3]. - Allegations include that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization [3]. - It is claimed that the company overstated the demand for its products and was unlikely to meet its financial guidance for fiscal year 2025 [3]. - The positive statements made by the defendants regarding the company's business and prospects are alleged to be materially misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by September 22, 2025, to participate in potential recovery [4]. - Upon registration, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of misleading statements and unsafe practices related to the promotion of knockoff versions of Wegovy, which may jeopardize its collaboration with Novo Nordisk [3][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is from April 29, 2025, to June 23, 2025 [3]. - Allegations include that Hims engaged in deceptive promotion and selling of illegitimate versions of Wegovy, risking patient safety [3]. - The lawsuit claims that the company's positive statements about its business and prospects were materially misleading and lacked a reasonable basis [3]. Group 2: Shareholder Actions - Shareholders who purchased HIMS shares during the class period are encouraged to register for the class action and may seek lead plaintiff status by the deadline of August 25, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm's Role - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].